Endocrinology, Internal medicine, Antidepressant, Anhedonia and Clinical psychology are his primary areas of study. The concepts of his Endocrinology study are interwoven with issues in Pharmacology and Sucrose. His work on Dopamine receptor D3, Receptor, Agonist and Ketanserin as part of general Internal medicine research is frequently linked to Pramipexole, bridging the gap between disciplines.
His Antidepressant study is concerned with Psychiatry in general. The study incorporates disciplines such as Developmental psychology, Construct validity, Craving, Depression and Animal models of depression in addition to Clinical psychology. Paul Willner works in the field of Depression, namely Mild stress.
His scientific interests lie mostly in Clinical psychology, Endocrinology, Internal medicine, Psychiatry and Pharmacology. His Clinical psychology research is multidisciplinary, incorporating elements of Psychotherapist, Intervention, Depression and Developmental psychology. His work on Depression deals in particular with Mild stress and Animal models of depression.
His study in Developmental psychology is interdisciplinary in nature, drawing from both Cognitive psychology, Reinforcement and Craving. In his study, Anhedonia is inextricably linked to Sucrose, which falls within the broad field of Endocrinology. His Pharmacology study incorporates themes from Antidepressant, Amphetamine and Anesthesia.
His main research concerns Clinical psychology, Psychiatry, Intellectual disability, Anger management and Intervention. His work deals with themes such as Psychotherapist, Cognition, Challenging behaviour and Depression, which intersect with Clinical psychology. Antidepressant and Mild stress are subfields of Depression in which his conducts study.
His research in Antidepressant intersects with topics in Ketamine, Pharmacology and Anhedonia. His study on Mental health is often connected to Prison population and Pandemic as part of broader study in Psychiatry. He has included themes like Developmental psychology and Aggression in his Intellectual disability study.
Paul Willner mostly deals with Clinical psychology, Psychiatry, Anger, Intellectual disability and Antidepressant. Paul Willner combines subjects such as Intervention, Neuroscience, Depression and Challenging behaviour with his study of Clinical psychology. His Depression research is mostly focused on the topic Mild stress.
In the field of Psychiatry, his study on Ventromedial prefrontal cortex, First episode and Psychopharmacology overlaps with subjects such as Pandemic and Diathesis. In Intellectual disability, Paul Willner works on issues like Mental health, which are connected to Psychological intervention and Anxiety. His Antidepressant research integrates issues from Ketamine, Anesthesia, Anxiogenic, Elevated plus maze and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation
Paul Willner.
Psychopharmacology (1997)
Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant.
Paul Willner;Anthony Towell;D. Sampson;S. Sophokleous.
Psychopharmacology (1987)
Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS
Paul Willner.
Neuropsychobiology (2005)
The validity of animal models of depression.
Paul Willner.
Psychopharmacology (1984)
Chronic mild stress-induced anhedonia : a realistic animal model of depression
Paul Willner;Richard Muscat;Mariusz Papp.
Neuroscience & Biobehavioral Reviews (1992)
The chronic mild stress (CMS) model of depression: History, evaluation and usage
Paul Willner.
Neurobiology of Stress (2017)
An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress.
Mariusz Papp;Paul Willner;Richard Muscat.
Psychopharmacology (1991)
The validity of animal models of predisposition to depression.
P Willner;P J Mitchell.
Behavioural Pharmacology (2002)
The neurobiology of depression and antidepressant action
Paul Willner;Jørgen Scheel-Krüger;Catherine Belzung.
Neuroscience & Biobehavioral Reviews (2013)
Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression.
Paolo S. D'Aquila;Paul Brain;Paul Willner.
Physiology & Behavior (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Utrecht University
Cardiff University
Swansea University
University of Kent
Abertay University
François Rabelais University
Swansea University
Royal London Hospital
Swansea University
University of Sussex
University of Maryland, College Park
Carnegie Mellon University
Maharaja Agrasen Institute of Technology (MAIT)
University of California, Santa Cruz
National Research Council (CNR)
University of Maryland Center For Environmental Sciences
Cranfield University
University of Bristol
Kobe University
Memorial Sloan Kettering Cancer Center
Queen Mary University of London
University of Utah
Heriot-Watt University
University of California, San Francisco
Harvard University
University of Groningen